+ Filter
Loading...
C4.4A
Loading...Anti-C4.4A Products
- Recombinant Human Anti-C4.4A Antibody (MHH-143)
-
- Derivation: Human
- Type: IgG
- Application: ELISA, WB, IF, FuncS
Compare
- Recombinant Anti-C4.4A Antibody (MOB-143)
-
- Derivation: Mouse
- Type: IgG
- Application: WB, IP, FuncS
Compare
- Mouse Anti-C4.4A Recombinant Antibody (clone NOV002YC) (HPAB-N0029-YC)
-
- Species Reactivity: Human
- Type: Mouse IgG2b, κ
- Application: FuncS
Compare
- Mouse Anti-C4.4A Recombinant Antibody (clone NOV002YC); scFv Fragment (HPAB-N0029-YC-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
Compare
- Mouse Anti-C4.4A Recombinant Antibody (clone NOV002YC); Fab Fragment (HPAB-N0029-YC-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FuncS
Compare
- Recombinant Anti-C4.4A Antibody Fab Fragment (MOB-143-F(E))
-
- Derivation: Mouse
- Type: Fab
- Application: WB, RIA, FuncS
Compare
- Recombinant Anti-C4.4A Antibody scFv Fragment (MOB-143-S(P))
-
- Derivation: Mouse
- Type: scFv
- Application: IP, IF, Biosensors, FuncS
Compare
- Recombinant Human Anti-C4.4A Antibody Fab Fragment (MHH-143-F(E))
-
- Derivation: Human
- Type: Fab
- Application: IF, WB, FuncS
Compare
- Recombinant Human Anti-C4.4A Antibody scFv Fragment (MHH-143-S(P))
-
- Derivation: Human
- Type: scFv
- Application: ELISA, WB, FC, FuncS
Compare
- Anti-C4.4a (clone M31-B01)-lysine-toxophore ADC (ADC-141CL)
-
- Target: C4.4a
- Linker: lysine
- Drug: toxophore loading
Compare
- Anti-C4.4a (clone B01-3)-lysine-toxophore ADC (ADC-142CL)
-
- Target: C4.4a
- Linker: lysine
- Drug: toxophore loading
Compare
More Infomation
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Anterior gradient 2 (AGR2) promotes cancer growth, metastasis, and resistance to therapy via unknown mechanisms. We investigated the effects of extracellular AGR2 signaling through the orphan glycosylphosphatidylinositol-linked receptor C4.4A in pancreatic ductal adenocarcinoma (PDAC).